Update of prognostic and predictive biomarkers in oropharyngeal squamous cell carcinoma: a review
✍ Scribed by Carolin M. Grimminger; Peter V. Danenberg
- Publisher
- Springer-Verlag
- Year
- 2010
- Tongue
- English
- Weight
- 434 KB
- Volume
- 268
- Category
- Article
- ISSN
- 0302-9530
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objectives/Hypothesis: The human papillomavirus (HPV) has been identified as a causative factor in 20% to 25% of all head and neck squamous cell carcinomas (HNSCC). Ongoing research suggests that the presence of HPV DNA in HNSCC predicts a positive prognosis with respect to disease‐
## Abstract A considerable subset of oropharyngeal squamous cell carcinomas (SCCs) are positive for human papillomavirus (HPV); however, delineating etiologically‐associated HPV infections from SCCs with concurrent HPV infection unrelated to tumorigenesis is challenging. Viral load assessment in bi
## Abstract ## Background and Objectives Expression of a panel of biomarkers, such as p53, Bcl‐2, Cyclin D1, c‐__myc__, p21ras, c‐erb B2, cytokeratin‐19 (CK‐19), and factor VIII–related antigen (FVIII‐RA), was studied together in anterior tongue tumors from the oral cavity and in posterior tongue
## Abstract ## BACKGROUND The survival of patients with head and neck squamous cell carcinoma (HNSCC) remains unaffected despite recent therapeutic advances. To reverse this trend, reliable and clinically applicable markers of tumor aggressiveness must be identified. One such marker may be the tum